Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Corporate Social Responsibility: What to do?
Kristianstad University, School of Health and Society.
2015 (English)Independent thesis Advanced level (degree of Master (One Year)), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

The focal point for this thesis is corporate social responsibility and how it can affect competitive advantage. This study is conducted within the pharmaceutical industry, an industry that is claimed to have a very high level of social responsibility. Thus, understanding what kind of CSR factors that contributes to competitive advantage might be seen as a relevant field of study.

The purpose if this study is to explain what kind of social responsibility factors that generates competitive advantage for pharmaceutical companies. The method used in this thesis is a content analysis, where pharmaceutical companies´ social responsibility reports are viewed and where the appearance of certain key words associated with CSR factors were counted. The following CSR factors have been used: human rights, labour practice, environment, fair operating practice, consumer issues and community involvement and development.  

Findings of this study indicate that consumer issues and community involvement and development are positively related to competitive advantage for pharmaceutical companies.  

The main limitations of this study are that findings are only applicable for the pharmaceutical industry. Also, since the sample is relatively small (N=25) it might be hard to replicate the findings of this study. This might alter the generalizability ability.

The original value of this study is that it is a step towards understanding what kind of CSR factors that contributes to competitive advantage for pharmaceutical companies. 

Key words: pharmaceutical, CSR, corporate social responsibility, competitive advantage. 

Place, publisher, year, edition, pages
2015. , 54 p.
Keyword [en]
Corporate social responsibilit, CSR, competetive advantage
National Category
Business Administration
Identifiers
URN: urn:nbn:se:hkr:diva-14763OAI: oai:DiVA.org:hkr-14763DiVA: diva2:856499
External cooperation
McNeil AB
Educational program
Degree of Bachelor of Science in Business and Economics
Uppsok
Social and Behavioural Science, Law
Supervisors
Examiners
Available from: 2015-09-28 Created: 2015-09-24 Last updated: 2015-09-28Bibliographically approved

Open Access in DiVA

fulltext(1133 kB)246 downloads
File information
File name FULLTEXT01.pdfFile size 1133 kBChecksum SHA-512
ee45cdb39f66974e34c2ed4a1d4bd3e18cc26e657a43cd19326145f61dc1ff6bc2f675111b3f16ed5e5d3d8b9f1cf4ceb5cfd0787f8ad6c7483b2793adf119bb
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Nilsson, Daniel
By organisation
School of Health and Society
Business Administration

Search outside of DiVA

GoogleGoogle Scholar
Total: 246 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 697 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf